2715. Pneumococcal Community-Acquired Pneumonia Attributed to PCV13 Serotypes in Hospitalized Adults: Comparison of the 50–64 and 65+ Age Groups

BACKGROUND: In healthy adults aged ≥65 years, direct immunization with the 13-valent pneumococcal conjugate vaccine (PCV13) was shown effective at preventing vaccine-type pneumococcal community-acquired pneumonia (pCAP) and invasive pneumococcal disease (IPD). Although PCV13 was licensed for use in...

Descripción completa

Detalles Bibliográficos
Autores principales: LeBlanc, Jason J, ElSherif, May, Ye, Lingyun, MacKinnon-Cameron, Donna, Ambrose, Ardith, Hatchette, Todd F, Lang, Amanda L S, Gillis, Hayley D, Martin, Irene, Demczuk, Walter, Andrew, Melissa K, Boivin, Guy, Bowie, William, Green, Karen, Johnstone, Jennie, Loeb, Mark, McCarthy, Anne, McGeer, Allison, Semret, Makeda, Trottier, Sylvie, Valiquette, Louis, Webster, Duncan, McNeil, Shelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810608/
http://dx.doi.org/10.1093/ofid/ofz360.2392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810608/
http://dx.doi.org/10.1093/ofid/ofz360.2392

Ejemplares similares